Preferred Label : ravulizumab;
Origin ID : M000646382;
Currated CISMeF NLP mapping
- MeSH narrower concept(s)
- Related record
https://www.hcsp.fr/explore.cgi/avisrapportsdomaine?clefr=1175
2022
France
public health guidelines
eculizumab
judgment
complement inhibitor, nos
complement inactivating agents
ravulizumab
patients
eculizumab
bacterial infectious disease, nos
Complement
eculizumab
Infectious disease
has patient
bacterial infections
ravulizumab
prophylactic treatment, nos
---
